Ammissione alle negoziazioni delle azioni ordinarie e dei warrant di pharmanutra s.p.a. sul mercato aim italia

Related News

• PharmaNutra Group: revenue increases +17%...

  PharmaNutra also climbs the annual IQVIA ranking in number of products sold, coming twelfth out of more...

• Two news patents approved in India and US...

  The Group obtains approval of the Cetilar® patent in the USA and new prospects unfold for SiderAL®...

Related Products

• (Italiano) ApportAL

  Sorry, this entry...

• Gestalys DHA

  Gestalys DHA is a nutritional supplement specifically formulated according to LARN (Recommended Nutrition...